Haberler›Güncel›Executives Leave Cassava, Maker of Controversial Alzheimer's Drug Executives Leave Cassava, Maker of Controversial Alzheimer's Drug admin • 19.07.2024 09:41 Paylaş: Twitter Facebook WhatsApp Reddit Pinterest The CEO and a chief scientist resigned just weeks after a federal grand jury brought fraud charges against a research collaborator. ← Friday Briefing A border crossing closed for months traps the sick and wounded in Gaza → Tavsiye Edilen Haberler 12/29/2025 New Cannabis Classification: Effects on Marijuana Research and Industry 12/28/2025 Many Older Americans Are Stopping Weight-Loss Medications 12/28/2025 Russia’s Likely Rejection of the New US-Ukrainian Peace Proposal Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. Δ
